Sabuncu Elifsu, David Julie, Bernède-Bauduin Claire, Pépin Sophie, Leroy Michel, Boëlle Pierre-Yves, Watier Laurence, Guillemot Didier
INSERM, U657, Paris, France.
PLoS Med. 2009 Jun 2;6(6):e1000084. doi: 10.1371/journal.pmed.1000084.
Overuse of antibiotics is the main force driving the emergence and dissemination of bacterial resistance in the community. France consumes more antibiotics and has the highest rate of beta-lactam resistance in Streptococcus pneumoniae than any other European country. In 2001, the government initiated "Keep Antibiotics Working"; the program's main component was a campaign entitled "Les antibiotiques c'est pas automatique" ("Antibiotics are not automatic") launched in 2002. We report the evaluation of this campaign by analyzing the evolution of outpatient antibiotic use in France 2000-2007, according to therapeutic class and geographic and age-group patterns.
This evaluation is based on 2000-2007 data, including 453,407,458 individual reimbursement data records and incidence of flu-like syndromes (FLSs). Data were obtained from the computerized French National Health Insurance database and provided by the French Sentinel Network. As compared to the preintervention period (2000-2002), the total number of antibiotic prescriptions per 100 inhabitants, adjusted for FLS frequency during the winter season, changed by -26.5% (95% confidence interval [CI] -33.5% to -19.6%) over 5 years. The decline occurred in all 22 regions of France and affected all antibiotic therapeutic classes except quinolones. The greatest decrease, -35.8% (95% CI -48.3% to -23.2%), was observed among young children aged 6-15 years. A significant change of -45% in the relationship between the incidence of flu-like syndromes and antibiotic prescriptions was observed.
The French national campaign was associated with a marked reduction of unnecessary antibiotic prescriptions, particularly in children. This study provides a useful method for assessing public-health strategies designed to reduce antibiotic use.
抗生素的过度使用是推动社区细菌耐药性产生和传播的主要因素。法国的抗生素消费量高于其他任何欧洲国家,肺炎链球菌对β-内酰胺类抗生素的耐药率也最高。2001年,法国政府启动了“保持抗生素有效”计划;该计划的主要组成部分是2002年发起的一场名为“抗生素并非必然选择”的运动。我们通过分析2000年至2007年法国门诊抗生素使用情况的演变,按治疗类别、地理区域和年龄组模式,报告了对该运动的评估结果。
本评估基于2000年至2007年的数据,包括453407458条个人报销数据记录以及类流感综合征(FLS)的发病率。数据来自法国国家医疗保险计算机数据库,并由法国哨点网络提供。与干预前时期(2000年至2002年)相比,在对冬季FLS频率进行调整后,每100名居民的抗生素处方总数在5年内下降了26.5%(95%置信区间[CI]为-33.5%至-19.6%)。法国所有22个地区均出现了下降,除喹诺酮类抗生素外,所有抗生素治疗类别均受影响。6至15岁幼儿的降幅最大,为35.8%(95%CI为-48.3%至-23.2%)。类流感综合征发病率与抗生素处方之间的关系发生了45%的显著变化。
法国的全国性运动与不必要抗生素处方的显著减少有关,尤其是在儿童中。本研究为评估旨在减少抗生素使用的公共卫生策略提供了一种有用的方法。